Guest guest Posted August 5, 2004 Report Share Posted August 5, 2004 Hello everyone, I recently wrote a letter to Environmental Defence in the USA in regards to their position on animal testing and suggested they support without stepping on the toes of PETA. here is the response I got 3 months later. at the bottom of the page is his email address feel free to follow up all the best Craig Thank you for contacting us regarding the High Production Volume Challenge Program. Environmental Defence welcomes efforts to prevent unnecessary animal testing in that program. This letter responds first to the specific points in your email, then offers some additional observations. First, please note that several provisions designed to minimize the need for additional animal tests are built into the HPV program: · the program calls for use of existing data wherever possible (occasionally, older data may be of inadequate scientific quality to be used); · even where data don't exist for a particular chemical, the program calls for grouping similar chemicals into "categories" wherever scientifically appropriate, and then extrapolating results within the category rather than conducting separate tests for each member of the category; and · the program expressly calls for non-animals tests where relevant non-animal test protocols exist. Unfortunately, non-animal tests don't yet exist for several critical health and ecological effects, which sometimes necessitates tests on laboratory rodents or fish. Your message urges that the HPV program should be delayed until the existing test data and human exposure information are thoroughly reviewed. With regard to existing data, please note that the HPV program requires that the sponsor of a chemical first submit a "robust summary" of existing data; only if data are not available is additional testing to be conducted. Environmental Defence carefully reviews the draft test proposals submitted by the companies that sponsor particular chemicals. In many cases, we have agreed with sponsors who concluded that no additional testing was needed. In a number of other cases, we disagreed with sponsors that additional animal testing was needed, and argued against their proposal to conduct those tests. In short, we conduct a careful scientific review of the facts in each case, and call for new testing only when it is needed to understand a chemical's hazards. We respectfully disagree with the suggestion that it is also necessary to first review human exposure information; in our view, such data cannot obviate the need for toxicity data on for these high-volume chemicals (I.e., ones produced in quantities exceeding one million pounds annually). In fact, it is these toxicity data that help establish which exposures are and are not acceptable. Finally, we also respectfully disagree with the implication that any chemical that is regulated should automatically be exempt from additional testing. The fact that a chemical is "regulated" in some way does not necessarily indicate that anything like adequate data exist for that chemical. For example, chemicals may be regulated because they are known to be poisonous at high doses, but this says nothing about whether lower doses can cause chronic effects such as mutations (which indicates cancer-causing potential), effects on the reproductive system or on development, or other serious health effects. In the absence of data, these lower-level exposures that cause chronic effects are the ones most likely to go unnoticed and uncontrolled. And so it is necessary to carry out tests for those effects even on chemicals known to have acute impacts. Moreover, animal data and other information on chemical risks can be highly effective in reducing our exposure to toxic chemicals even outside of formal regulatory settings. When such information is made public, the resulting pressure to correct the problem often prods companies that make and use chemicals to change their practices far more quickly than regulators can act. The dramatic results of the federal Toxics Release Inventory (TRI) and California's Proposition 65 ? programs highly dependent on having reliable data on chemical hazards ? demonstrate that information disclosure itself triggers steps to reduce exposures. Air emissions of carcinogens and reproductive toxicants covered by TRI fell by approximately 50% percent nationwide between 1988 and 1997, while in California, where the same chemicals were also covered by the disclosure requirements of Prop. 65, the same air emissions fell by approximately 85%. These important risk-reducing incentive programs would not have happened without strong data on toxicity, since both TRI and Prop. 65 apply only to chemicals classified as toxic. Likewise, 3M moved voluntarily to withdraw a range of widely used products after finding that the chemicals they contained were toxic based on animal tests. We would also like to offer a number of additional observations. First, there is good news: far less new animal testing may be required under the program than had originally been expected. EPA analysed the HPV submissions covering the first 850 chemicals, and found that new testing was proposed as the means to fill only about 3.5% of the health data gaps that were identified, and 6.7% of the ecological data gaps; the new testing would be conducted on rats and mice for health effects, and on fish and invertebrates for ecological effects. The remaining information was proposed to be provided from existing data (some of which had not previously been published but has been brought to light by this program) on the same chemical, or by extrapolating from data on similar chemicals. While some of these proposals may turn out not to pass scientific muster, it's clear that everyone involved in the program has been making major efforts to minimize use of animal testing. More generally, we believe it is important to note that the HPV program was established after we documented, and EPA and industry both separately confirmed, that there were massive gaps in the public availability of even basic toxicity data on widely and heavily used chemicals. We continue to believe that such gaps are unacceptable, because they keep consumers as well as government from acting to reduce unnecessary risks to health and the environment. And if industry has the data but they aren't public, then industry has little incentive to take action on its own. The HPV Challenge Program was created to address the appalling lack of public access to data on the hazards posed by industrial chemicals that are released into the environment and to which people ? and animals ? are likely to be exposed. The program asks chemical manufacturers to start living up to their responsibility to know ? and tell the public ? about the toxic effects of the chemicals they make and use in their products. Because of the vast number of chemicals now on the market, HPV focuses on the ones produced in the highest volumes (one million pounds or more annually). Far from being uninformative, the test protocols used under the program provide the basic data needed to screen chemicals for their potential hazard to humans and other living organisms. The real controversy is the use of laboratory animals in some of this testing. Everyone who works on chemicals wishes there were a set of reliable non-animal tests that could be used for all toxicity-evaluation purposes, but the fact is that such tests don't now exist for several serious health and ecological effects. And there is abundant scientific evidence that data from appropriate animal tests are critical to predicting impacts on humans and other organisms. This is true both in evaluating toxicity, and in developing drugs to treat human and animal illness. Recent advances in genetic information make it clearer than ever that animal and human biology are fundamentally similar at the cellular level (which is where toxic effects are generally exerted). It is worth noting that animal rights and animal welfare organizations have been instrumental in making sure that unnecessary animal testing is avoided. A good case can be made that in years past too little effort went into developing and implementing non-animal alternatives to traditional animal testing procedures. While there may still be differences of opinion about the necessity for particular animal tests, there is no longer disagreement about the importance of doing animal tests only when there is no viable alternative. We fully recognize that the use of animal testing to protect the health of humans and other living organisms is a difficult issue. Some animal rights activists take the coherent, but in our view extreme, position that no animal testing, however useful or even essential, is morally acceptable. Others see a need to balance animal welfare against health and environmental quality concerns. We should work hard to listen to and respect each other's opinions, and to avoid misrepresenting them. We do not believe in, and would never advocate for, animal testing unless it provides information that is critical to understanding chemical hazards. We respect the values that lead some people to oppose all animal testing, even where there are no scientifically valid alternatives and no matter how useful that information is in protecting human health and the environment. We recognize the deeply held moral conviction of some that humans do not have the right to use any living creature for human purposes, although we do not share that position. While Environmental Defence believes that limited animal testing at present remains necessary within the constraints described above, we share a common interest in avoiding unnecessary testing on animals and in advancing technologies that will further reduce the need for animal testing. Although some of our differences may never be fully reconciled, animal-welfare concerns are very much a part of our thinking and continue to help shape our focus and priorities as we work to protect the health of all of the living things on our planet. Some bottom-line conclusions on this complex issue: 1. Animal testing can help establish important information about chemical toxicity, information that meaningfully influences the decisions of manufacturers, regulators, and consumers. 2. In some cases the needed information can be obtained without animal testing ? and in such cases it is morally wrong to subject animals to unnecessary tests. Animal-rights and animal-welfare organizations played a crucial role in raising consciousness about this moral imperative, and continue to hold us all to this standard: No unnecessary animal testing. 3. In many cases the needed information cannot be obtained without animal testing. In these situations, some organizations nonetheless oppose animal testing, arguing that it is immoral to acquire toxicity information at the expense of animals under any circumstances. Other organizations, including Environmental Defence, believe that test animals' needs must be balanced against other needs, including the protection of humans, wildlife, and the environment. In short, this is an area where Environmental Defence must respectfully but vigorously disagree with some other organizations. 4. Disagreements will inevitably arise about which specific testing falls under #2 above and which falls under #3. It should be a high priority for scientists to develop new non-animal approaches to toxicity evaluation, and for the relevant scientific and governmental authorities to approve the non-animal tests for use. As viable non-animal options become available, previously debatable testing (described in #3 above) moves into #2, and becomes unacceptable in the view of all. Yours truly, Fred Krupp, President Environmental Defence Office_of_Fred_Krupp Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.